Chimerix Inc (NAS:CMRX)
$ 0.938 -0.0042 (-0.45%) Market Cap: 84.07 Mil Enterprise Value: -73.57 Mil PE Ratio: 0 PB Ratio: 0.48 GF Score: 51/100

Q4 2020 Chimerix Inc Earnings Call Transcript

Feb 25, 2021 / 01:30PM GMT
Release Date Price: $10.67 (+4.81%)
Operator

Good morning, ladies and gentlemen, and welcome to the Chimerix Fourth Quarter and Year-End 2020 Earnings Conference Call. I would now like to introduce you to your host for today's call, Michelle LaSpaluto, vice president of strategic planning and investor relations at Chimerix. Please proceed.

Michelle LaSpaluto
Chimerix, Inc. - VP of Strategic Planning & IR

Thank you. Good morning, everyone, and welcome to the Chimerix Fourth Quarter and Year-End 2020 Financial and Operating Results Conference Ccall.

This morning, we issued 2 press releases on our fourth quarter operating update and the second one on the ongoing COVID-19 trial of DSTAT. You can access these press releases in our Investors section of the website.

With me on today's call are President and Chief Executive Officer, Mike Sherman; Chief Medical Officer, Allen Melemed; Chief Financial and Business Officer, Mike Andriole, Chief Science Officer, Randall Lanier; and our newest member of the team, too, Chief Interim Technology Officer, Josh Allen.

Before we begin, I

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot